Volume 64, Issue 6, Pages (December 2003)

Slides:

Advertisements

Similar presentations

LDL cholesterol in CKD—to treat or not to treat?

Advertisements

Volume 54, Issue 2, Pages (August 1998)

Volume 62, Issue 3, Pages (September 2002)

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Volume 91, Issue 1, Pages (January 2017)

Volume 66, Issue 4, Pages (October 2004)

Volume 63, Issue 6, Pages (June 2003)

Naïve and central memory T-cell lymphopenia in end-stage renal disease

The US Renal Data System “Pie Chart of Death”

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Volume 62, Issue 3, Pages (September 2002)

Volume 66, Issue 4, Pages (October 2004)

Progression of renal failure and hypertensive nephrosclerosis

Volume 64, Issue 3, Pages (September 2003)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Volume 70, Pages S21-S25 (December 2006)

In Reply to ‘The US Renal Data System “Pie Chart of Death”’

George A. Kaysen, Burl R. Don

Volume 80, Issue 9, Pages (November 2011)

Comorbidity and confounding in end-stage renal disease

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 81, Issue 2, Pages (January 2012)

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Volume 70, Issue 11, Pages (December 2006)

Patient selection affects end-stage renal disease outcome comparisons

Volume 76, Issue 10, Pages (November 2009)

LDL cholesterol in CKD—to treat or not to treat?

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Acute myocardial infarction in patients with end-stage renal disease

The calcium–phosphorus in guidelines for CKD-MBD

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Volume 58, Issue 2, Pages (August 2000)

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

Elevated risk of stroke among patients with end-stage renal disease

Volume 87, Issue 1, Pages (January 2015)

The global challenge of chronic kidney disease

Volume 80, Issue 6, Pages (September 2011)

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 70, Issue 3, Pages (August 2006)

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Volume 64, Issue 2, Pages (August 2003)

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors Barry M. Brenner, Joann Zagrobelny

Peritoneal dialysis in Mexico

Clinical benefits of slowing the progression of renal failure

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Michael R. Lattanzio, Matthew R. Weir Kidney International

Volume 68, Issue 5, Pages (November 2005)

Charles A. Herzog Kidney International

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Stephen G. Rostand, Tilman B. Drüeke Kidney International

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

Volume 75, Issue 7, Pages (April 2009)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Hemodialysis access failure: a call to action—revisited

Volume 57, Issue 4, Pages (April 2000)

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Presentation transcript:

Volume 64, Issue 6, Pages 2291-2297 (December 2003) Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease Tomohiro Osanai, Masayuki Nakamura, Satoko Sasaki, Hirofumi Tomita, Masayuki Saitoh, Hiroshi Osawa, Hideaki Yamabe, Shuichi Murakami, Koji Magota, K.E.N. Okumura Kidney International Volume 64, Issue 6, Pages 2291-2297 (December 2003) DOI: 10.1046/j.1523-1755.2003.00334.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Relationship between plasma coupling factor 6 (CF6) level and serum creatinine concentration in patients with end-stage renal disease (ESRD). Kidney International 2003 64, 2291-2297DOI: (10.1046/j.1523-1755.2003.00334.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between plasma coupling factor 6 (CF6) level and cardiovascular events in patients with end-stage renal disease (ESRD). Abbreviations are: IHD, ischemic heart disease (myocardial infarction plus angina); CHF, congestive heart failure. Kidney International 2003 64, 2291-2297DOI: (10.1046/j.1523-1755.2003.00334.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between plasma asymmetric dimethylarginine (ADMA) level and duration of dialysis treatment (month) in patients with end-stage renal disease (ESRD). Kidney International 2003 64, 2291-2297DOI: (10.1046/j.1523-1755.2003.00334.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between plasma asymmetric dimethylarginine (ADMA) level and cardiovascular events in patients with end-stage renal disease (ESRD). Abbreviations are: IHD, ischemic heart disease (myocardial infarction plus angina); CHF, congestive heart failure. Kidney International 2003 64, 2291-2297DOI: (10.1046/j.1523-1755.2003.00334.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Relationship between plasma coupling factor 6 (CF6) level and plasma asymmetric dimethylarginine (ADMA) level in patients with end-stage renal disease (ESRD). Kidney International 2003 64, 2291-2297DOI: (10.1046/j.1523-1755.2003.00334.x) Copyright © 2003 International Society of Nephrology Terms and Conditions